A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is an open-label, multicenter, phase II clinical study designed to evaluate the preliminary efficacy, safety, and tolerability of SHR-7787 in combination with Adebrelimab in patients with limited-stage small cell lung cancer.
Epistemonikos ID: b728646f77ef25cf480b443537da59ae1ca1e3d5
First added on: Sep 03, 2026